Position in ACET
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$19,793
-$3,994 QoQ
Shares Held
2,291
-34.4% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 56 holders
Holding Since
Sep 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACET Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,847,278 across 523 Biotechnology names. ACET ranks #402 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in ACET
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,793 | 2,291 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $23,787 | 3,493 | Shares | Defined | 2026-05-15 | |
| 2025-06-30 | $44,056 | 72,226 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $1,269 | 1,683 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,622 | 7,925 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $387,227 | 268,909 | Shares | Defined | 2025-02-14 | |
| 2024-06-30 | $1,351,572 | 1,117,005 | Shares | Defined | 2024-10-17 | |
| 2024-03-31 | $9,558,165 | 4,067,305 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $5,289,745 | 2,798,809 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $5,255,834 | 3,836,377 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $5,948,255 | 2,447,843 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $9,445,694 | 1,639,878 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $14,590,559 | 1,632,054 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $23,614,824 | 1,660,677 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $23,852,557 | 1,633,737 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $298,670 | 14,956 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $250,717 | 14,335 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $122,128 | 15,578 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $153,650 | 14,932 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $6,226 | 476 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $221,862 | 15,791 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $114,975 | 9,670 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||